skip to main content




Back to all Representative Matters
Oct 10, 2018

MediPharm Labs Corp. Completes Qualifying Transaction and Commences Trading on the TSXV

Melanie Cole and Amy Marcen-Gaudaur

On October 1, 2018, MediPharm Labs Corp. (formerly POCML 4 Inc.) (TSXV: LABS) (“MediPharm Labs” or the “Company”) completed its business combination with MediPharm Labs Inc. (the “Target”), which resulted in a reverse take-over of the Company by the shareholders of the Target and constituted the “Qualifying Transaction” of the Company as such term is defined in the policies of the TSX Venture Exchange (the “TSXV”). On October 4, 2018, the shares of MediPharm Labs began trading on the TSXV under the ticker symbol “LABS”.

MediPharm Labs is research-driven and focused on downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification. MediPharm Labs, through its subsidiary, provides B2B contract processing of cannabis to Canadian authorized licensed producers and appropriate international growers, supplying integrity-assured cannabis oil to qualified companies for sale under their own brand. In addition, MediPharm Labs will supply raw materials, formulations, processing and packaging for the creation of ready-to-sell advanced derivative products. Through its Australian subsidiary, MediPharm Labs has also completed its application process with the federal Office of Drug Control to extract and import medical cannabis products in Australia.

Aird & Berlis LLP represented MediPharm with a team comprised of Melanie Cole, Daniel Everall and Amy Marcen-Gaudaur (capital markets) and Brandon Church (corporate services).

Areas of Expertise

Related Industries

Related Representative Matters

Representative Matters
Allied Properties REIT Completes $345 Million Public Equity Offering Margaret T. Nelligan, Sherri M. Altshuler, Anne E. Miatello, Melanie Cole, Liam Tracey-Raymont, Amy Marcen-Gaudaur, Michael D. Smith, Neill Kalvin, Zale Skolnik and Barbara Worndl Jun 24, 2019 Allied Properties Real Estate Investment Trust, a leading owner, manager and developer of distinctive urban workspace in Canada’s major cities and network-dense urban data centres in Toronto that form Canada’s hub for global connectivity, recently completed a $345 million public equity offering o...
Representative Matters
MediPharm Labs Completes $75 Million Bought Deal Financing Melanie Cole, Amy Marcen-Gaudaur, Meredith McCann and Barbara Worndl Jun 18, 2019 MediPharm Labs Corp., a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, recently completed a $75 million bought deal offering of common shares.
Representative Matters
Feronia Inc. Completes US$19.3 Million Private Placement and Debt Settlement Richard M. Kimel, Amy Marcen-Gaudaur and Clair Affleck-Jacques Jun 06, 2019 Feronia Inc. recently completed a US$19.3 million private placement of common shares issued to existing shareholders Straight KKM 2 Limited, CDC Group plc and Golden Oil Holdings Limited at an issuance price of CAD$0.075 per share.